Pharmacological Properties of 5-Hydroxytryptamine<sub>4</sub>Receptor Antagonists on Constitutively Active Wild-Type and Mutated Receptors
2000 · Molecular Pharmacology · 48 citations
https://doi.org/10.1124/mol.58.1.136
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
284
Papers
16.9K
Citations
72
h-index
198
i10-index
Richard M. Eglen is an academic researcher from PerkinElmer (United States). The author has contributed to research in topics: Receptor Mechanisms and Signaling & Neuropeptides and Animal Physiology & Ion channel regulation and function. The author has an h-index of 72, co-authored 242 publications.
Click to start Chat